伊良部 仁, 加畑映理子, 山宮麻里, 宮下健悟, 井上巳香, 前馬秀昭, 酒詰 忍, 井上なつみ, 清水正樹, 太田和秀.
ネフローゼ症候群, 腎機能低下で発見されたループス腎炎の1男児例 急性期の治療を考察する.
日本小児腎不全学会雑誌 2018; 38: 193-196.

城戸内健介, 伊川泰広, 井上なつみ, 加藤明子, 谷内江昭宏.
タンパク漏出性胃腸症を合併したyersinia enterocolitica腸炎の1歳男児.
小児感染免疫 2018; 30: 121-126.

太田邦雄.
【おさえたい診療ガイドラインのツボ-小児循環器編-】各診療ガイドラインのポイント 児童生徒の突然死防止.
小児科診療 2018; 81: 919-924.

Takakura M, Shimizu M, Mizuta M, Inoue N, Tasaki Y, Ohta K, Furuichi K, Wada T, Yachie A.
Successful treatment of rituximab- and steroid-resistant nephrotic syndrome with leukocytapheresis.
J Clin Apher. 2018; 33: 409-411. doi: 10.1002/jca.21613.

清水正樹.
【日常診療にひそむ小児リウマチ性疾患】小児リウマチ性疾患の診断と治療 全身型若年性特発性関節炎とマクロファージ活性化症候群.
小児科診療 2018; 81: 777-782.

笠原理愛, 伊川泰広, 中川 亮, 高倉麻衣子, 山田真平, 中村美穂, 白橋徹志郎, 中山祐子, 黒田文人, 根本育美, 井上なつみ, 池野 郁, 和田英男, 谷内江昭宏.
繰り返す末梢気道攣縮に対してセボフルランが著効したI-cell病の1例.
小児科臨床 2018; 71: 1105-1110.

谷内江昭宏.
慢性活動性EBV感染症と類縁疾患.
小児科 2018; 59: 1061-1069.

Shibata H, Yasumi T, Shimodera S, Hiejima E, Izawa K, Kawai T, Shirakawa R, Wada T, Nishikomori R, Horiuchi H, Ohara O, Ishii E, Heike T.
Human CTL-based functional analysis shows the reliability of a munc13-4 protein expression assay for FHL3 diagnosis.
Blood. 2018; 131: 2016-2025. doi: 10.1182/blood-2017-10-812503.

種市尋宙, 太田邦雄.
【小児の治療指針】救急場面における初期対応 溺水.
小児科診療 2018; 81: 86-88.

Asano T, Okada S, Tsumura M, Yeh TW, Mitsui-Sekinaka K, Tsujita Y, Ichinose Y, Shimada A, Hashimoto K, Wada T, Imai K, Ohara O, Morio T, Nonoyama S, Kobayashi M.
Enhanced AKT Phosphorylation of Circulating B Cells in Patients With Activated PI3Kδ Syndrome.
Front Immunol. 2018; 9: 568. doi: 10.3389/fimmu.2018.00568.

Wada T, Toma T, Miyazawa H, Koizumi E, Shirahashi T, Matsuda Y, Yachie A.
Longitudinal analysis of serum interleukin-18 in patients with familial Mediterranean fever carrying MEFV mutations in exon 10.
Cytokine. 2018; 104: 143-146. doi: 10.1016/j.cyto.2017.10.007.

Wada T, Toma T, Miyazawa H, Koizumi E, Shirahashi T, Matsuda Y, Yachie A.
Characterization of skin blister fluids from children with Epstein-Barr virus- associated lymphoproliferative disease.
J Dermatol. 2018; 45: 444-449. doi: 10.1111/1346-8138.14226.

Koga T, Migita K, Sato T, Sato S, Umeda M, Nonaka F, Fukui S, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Ueki Y, Masumoto J, Agematsu K, Yachie A, Yoshiura KI, Eguchi K, Kawakami A.
MicroRNA-204-3p inhibits lipopolysaccharide-induced cytokines in familial Mediterranean fever via the phosphoinositide 3-kinaseγpathway.
Rheumatology (Oxford). 2018; 57: 718-726. doi: 10.1093/rheumatology/kex451.

谷内江昭宏.
【ヘルペスウイルス感染症の最近の知見】EBウイルス 急性EBウイルス感染症.
臨牀と研究 2018; 95: 366-371.

太田邦雄.
小児診療初期対応コース(JPLS)について.
東京小児科医会報別冊 2018; 36: 46-49.

Shimizu M, Inoue N, Mizuta M, Nakagishi Y, Yachie A.
Characteristic elevation of soluble TNF receptor II: I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis.
Clin Exp Immunol. 2018; 191: 349-355. doi: 10.1111/cei.13026.

Schulert GS, Minoia F, Bohnsack J, Cron RQ, Hashad S, KonÉ-Paut I, Kostik M, Lovell D, Maritsi D, Nigrovic PA, Pal P, Ravelli A, Shimizu M, Stanevicha V, Vastert S, Woerner A, de Benedetti F, Grom AA.
Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis.
Arthritis Care Res (Hoboken). 2018; 70: 409-419. doi: 10.1002/acr.23277.

Fujiki T, Nishimura R, Ikawa Y, Noguchi K, Mase S, Kuroda R, Araki R, Maeba H, Yachie A.
Hearing impairment accompanied with low-tone tinnitus during all trans retinoic acid containing chemotherapy.
Pediatr Blood Cancer. 2018; 65. doi: 10.1002/pbc.26864.

Tasaki Y, Shimizu M, Takarkura M, Ohta K, Yachie A.
Urinary aquaporin-2 as a possible objective biomarker of nocturnal polyuria.
Pediatr Int. 2018; 60: 192-194. doi: 10.1111/ped.13443.

Kinjo N, Hamada K, Hirayama C, Shimizu M.
Role of plasma exchange, leukocytapheresis, and plasma diafiltration in management of refractory macrophage activation syndrome.
J Clin Apher. 2018; 33: 117-120. doi: 10.1002/jca.21570.